Dehydrogenases
are widely employed as biocatalysts for the production
of optically pure chemicals under mild conditions. Most dehydrogenases
are nicotinamide cofactor (NADPH or NADH)-dependent oxidoreductases.
7β-Hydroxysteroid dehydrogenase (7β-HSDH) is a key enzyme
for the biochemical synthesis of ursodeoxycholic acid (UDCA). To date,
all reported 7β-HSDHs are strictly NADPH-dependent enzymes.
However, compared with NADPH, NADH is much more economical, making
it the preferential cofactor for synthetic applications of dehydrogenases.
In this work, a recombinant 7β-HSDH originating from Ruminococcus torques was rationally engineered to
alter its cofactor dependence using a strategy referred to as Cofactor
Specificity Reversal: Small-and-Smart Library Design (CSR-SaSLiD),
which is based on structural information and conservative sequence
alignment. We rationally designed a small-and-smart library containing
only five mutants that enabled the quick identification of target
variants. Compared with the wild type, the resultant mutant, G39D,
showed a 953 000-fold switch in cofactor specificity from NADPH
to NADH, and another mutant, G39D/T17A, resulted in 223-fold enhanced
activity with NADH. The structural mechanism regarding the effect
of mutation on the reversal of cofactor preference and improvement
of catalytic activity was elucidated with the aid of molecular dynamics
simulation. Furthermore, it was confirmed that the CSR-SaSLiD strategy
can be extended to other 7β-HSDHs. This work provides an efficient
approach to altering cofactor preference and subsequently recovering
the enzymatic activity of dehydrogenases for cost-effective biotechnical
applications.